| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . |
| # |
Score |
Template |
Links and tools | %id | First |
RFIFMVPFLCLIVIMRGTFTPLLLEMRKKPFYWIKWSFVGFVLFYAPITFAAAYGPGWLIAGTWQITIVAGVLLSPLFYVKQDMPGGPQLIRQKIPLVSLGTSVIILIGAALIQLQHAESLSGRMLLFSVLPVVIAAFAYPLGNRRMLEEYGGRLDTFQRVLGMTLASLPFWLILAAYGWWSDGLPTASQTVQSFIVAVSSGIIATVLFFWATDMVRDNPQKLAAVEATQSGEVIFALLGEIVLLSGVFPSLLSFAGLFIIIAGMMLH | Last |
| 1 | -127.000 | PF13536.6; YJLA_BACSU/38-305; Putative multidrug resistance efflux transporter |
ali |
100 | 1 | RFIFMVPFLCLIVIMRGTFTPLLLEMRKKPFYWIKWSFVGFVLFYAPITFAAAYGPGWLIAGTWQITIVAGVLLSPLFYVKQDMPGGPQLIRQKIPLVSLGTSVIILIGAALIQLQHAESLSGRMLLFSVLPVVIAAFAYPLGNRRMLEEYGGRLDTFQRVLGMTLASLPFWLILAAYGWWSDGLPTASQTVQSFIVAVSSGIIATVLFFWATDMVRDNPQKLAAVEATQSGEVIFALLGEIVLLSGVFPSLLSFAGLFIIIAGMMLH |
268 |
| 2 | -14.600 | PF06027.12; S35F2_HUMAN/35-334; Solute carrier family 35 |
ali follow.. |
10 | 45 | NYCLLFLIYTVMLAFRSGSDNLLVILKRKWWKYILLGLAANYVIVRAYQYTTLTSVQLLDCFGIPVLMALSWFI----------------LHARYRVIHFIAVAVCLLGVGTMVGADIEDNSGSDVLIGDILVLLGASLYAI-EYIVKKLSRQEFLGMVGLFGTIISGI---QLLIVEYKDIASIHWDWKIALLFVAFALCMFCLYSFMPLVIKVTSATSVNLGI-----LTADLYSLFVGLFLFGYKF-SGLYILSFTVIMVGFILY |
298 |
| 3 | -10.300 | PF04142.15; O16658_CAEEL/7-326; Nucleotide-sugar transporter |
ali follow.. |
14 | 94 | .........................................AIMYVIQNNLLFFALKKLDAATYQVTYQLKILTTAIFSV--------TMLGKSLHRYNWMALILLTAGVALVQYPSGDSTTSKSNILGLGAVLAACFSSGFAGEKILKTSKVSLRNIQLAFFSVFGALLVCWLYDWQAISDDGFLRGYNGVIWIVVLLQAGLVIALVVKYADNILKG----------AVSLSIILSSFTSWLVLGDLTITTTFAIGATVVIFATFLY |
319 |
| 4 | -9.740 | PF00892.20; YDED_BACSU/160-296; EamA-like transporter family |
ali follow.. |
16 | 3 | ................................................................................................................................AVVWGVLSGFAAAF---LYAVGLLNKFDSLVVVGWAMIIGGFALGFIHPPWQLDFQRLTAEAYAYILFVILFGTMIAFWFFIKSLESLSPKETSLLG-----SLEPLSAVVTTVVWLKAPF-GSFQWIGAICIIGITLI. |
134 |
| 5 | -9.670 | PF16913.5; PUP2_ARATH/6-340; Purine nucleobase transmembrane transport |
ali follow.. |
12 | 81 | ......................................IVVGLLVGFDNYLYSYGLAYIPVSTASLIISAQLGFTALF--------AFFMVKQKFTPFTINAIVLLTGGAVVLALNSDSNETHKEYVVGFIMTLGAALLYGF-VELSYKKSGQRITYTLALEFQMVLCFAATCVCLVGMLAAGDFKVKHALSLYYVVIVFTAIIWQAFFVGAIGLIFCASSLVSGIMVS--ALLPVTVILAVICFQEKF-QAGKGVALALSLWGSVSY |
325 |
| 6 | -8.660 | PF05653.14; NIPA2_HUMAN/8-302; Magnesium transporter NIPA |
ali follow.. |
11 | 46 | .........................YLKEWLWWAGLLSMGAGEVANFAAYA--FAPATLVTPLGALSVLVSAILSSYF------------LNERLNLHGKIGCLLSILGSTVMTLNEMSHKLGDPGFVVFATLVVIVALILI---VVGPRHGQTNILVYITICSVIGAFSVSCVKGLGIAIKELFAGKPVLRHPLAWILLLSLIVCVSTINYLNRALDIFNTSIVTPIYYVFFTTSVLTCSAILFKPVDDVIGTLSGFFTIIVGIFL. |
288 |
| 7 | -8.130 | PF03151.16; D7TJE0_VITVI/103-390; Triose-phosphate Transporter family |
ali follow.. |
10 | 68 | ......................................IPVAVCHALGHVTSNVSFAAVAVSFTHTIKALEPFFNAAA--------SQFILGQSIPLTLWLSLAPVVLGVSMASLTELS-FNWIGFISAMISNISFTYRSIYSKKAMTDMDSTNIYAYISIIALIV-CIPPALIVEGPQLMKHGF-AKVGLTKFLSDLFWVGMFYHLYNQLATNTLERVAPLTHAVGNV--LKRVFVIGFSILVFGNKI-STQTGIGTCVAIAGVAMY |
287 |
| 8 | -7.330 | PF10639.9; A7SF34_NEMVE/12-127; Putative transmembrane family 234 |
ali follow.. |
20 | 47 | ..................................................................................................................................................................................................YMVPFLLNQSGSVLFYLTLGSADLS----LAVPITNSLTFIMTTLTGR-ILGEESCKTETYIGMLLVVGGVSL. |
114 |
| 9 | -7.270 | PF08627.10; CRTP3_DICDI/55-397; CRT-like, chloroquine-resistance transporter-like |
ali follow.. |
14 | 39 | .YGYLPIFLVAMWYKMYCTSDVPKETRNFPQYKFVIMGLLDAINGFFVVIGGVSTSGPLQQLLNQAIIPFTMIASFIF------------LRERYSLFQLGGAAVILGGVIVSLIPSLGGSSGGNILFYNFFYLISVIPGALSNDIAFQSIDMDLQFWDCLYQSLFGSILFPVNNWLPPPATIKFTEIIPSMRDGALCLGG-WIIVLIYMTVNIAYNIFILLVLKHAGATVYSIANTVILPLTNIFFSIHSALSVAGLLLILFGLGGY |
343 |
| 10 | -7.260 | PF08449.11; S35B4_DROME/6-325; UAA transporter family |
ali follow.. |
13 | 70 | ..........................................ALFFGANVCNNYAFNFNIPMPLHMIFRSGSLMANMI--------GIVLLKKRYNLRQYSSVAMITAGIILCTLVSSGDVKDNTHTVGIGLLTIALLV--MGIYQEVIYKKYGKHPSEALFFTHMLPLPGFLIMAGNIVQH--EWKFPLMLFYLLCNVVTQYVCISAVYVLTTECAS-----LTVTLVVTLRKFVSLLFSIIYFRNPF-TLNHWVGTILVFFGTILF |
316 |